Dhoot Transmission IPO: Listing pop, richer valuation

Listing day: the numbers investors shared

Dhoot Transmission listed at ₹1,200 per share on the NSE. That was a 37.77% premium to the IPO price of ₹871. On the BSE, the stock opened at ₹1,193.80, up 37.06% versus the issue price. Social media chatter focused on the size of the pop and what it implies for expectations. The listing price also implied a market capitalisation of ₹24,546 crore at debut. Many posts framed the move as a strong demand signal. Others pointed out that a sharp first print can front-load returns. The immediate debate moved quickly from “listing gains” to “what valuation now assumes.”

Grey market cues: GMP trended up, then the stock jumped

The IPO’s grey market premium was widely tracked into listing. One update cited a GMP of +258 on the day being discussed. Another data point put GMP at ₹240 as of August 9, about 27.6% of the ₹871 upper band. Over the past 15 sessions referenced in posts, GMP was said to fluctuate between ₹146 and ₹276. Commentators used that range to argue sentiment was improving into the close. The indicated GMP levels were pointing to a strong debut even before listing. The actual listing around 37% landed above the near-28% GMP-based indication mentioned. That mismatch became a key talking point, especially around how much optimism may already be priced in.

Post-IPO valuation reset: market cap and P/E moved up

A recurring theme online was that the listing pop also rerated the stock. At the IPO price, several broker notes anchored valuation around 44.9x FY26 post-issue earnings. Post listing, the P/E was cited at 61.85x, up from 44.89x before the IPO. That change matters because it shifts the market’s expectations for future earnings delivery. Investors also referenced dilution effects, noting post-issue EPS numbers rather than pre-issue figures. Some posts compared the IPO valuation to peer multiples cited at 56.8x to 58.5x. After listing, the “discount to peers” argument looked less straightforward at the traded price. The table below captures the key numbers shared in discussions.

FY26 growth: income up 31%, PAT up 12%

Posts frequently cited FY26 financial growth as support for demand. Total income was reported at ₹4,563.70 crore in FY26 versus ₹3,472.24 crore in FY25. Profit after tax (PAT) increased to ₹396.84 crore from ₹353.89 crore a year earlier. This establishes that revenue growth outpaced profit growth in the latest year cited. A longer trajectory was also discussed using FY24 to FY26 income growth. Total income was cited at ₹2,799.32 crore in FY24, then ₹3,472.24 crore in FY25, then ₹4,563.70 crore in FY26. Revenue from operations was also shared as ₹2,797.73 crore in FY24, ₹3,444.86 crore in FY25, and ₹4,524.95 crore in FY26. These numbers were used to argue that scale is rising quickly. At the same time, several posts cautioned that valuation after listing demands continued execution.

Margins and efficiency: what slipped, and what was adjusted

Beyond top-line growth, margin and return ratios drew scrutiny. PAT margin was cited as declining from 10.19% in FY25 to 8.70% in FY26. EBITDA margin was also shown lower at 15.71% in FY26 versus 17.15% in FY25 in one metric table. ROE was listed at 16.30% in FY26 compared with 35.60% in FY25. ROCE was listed at 19.14% in FY26 compared with 29.66% in FY25. Some users argued these declines could reflect capital changes around the issue, not only operations. A separate note said that excluding ₹1,022.56 crore of unused cash from a recent share issue, ROE stood at 28.10% and ROCE at 27.83% in FY26. That adjusted view featured prominently in threads debating “quality of returns.” The takeaway was that interpretation depends on whether investors treat cash as productive capital today.

Broker framing pre-listing: valuation discount to peers

Several analyst notes circulating online carried a “Subscribe” view before listing. Those notes generally used about 44.9x FY26 post-issue P/E at the upper price of ₹871. Choice Securities was cited as calculating that multiple at roughly a 30% discount to a listed peer average of 58.5x. Another comparison mentioned a 56.8x peer average, with the IPO multiple around 44.33x on a post-issue diluted EPS of ₹19.65. Across notes, three themes were repeated in posts: positioning in electric 2W and 3W harnesses, favourable valuation versus peers, and strong growth over prior years. One note also cited a four-year revenue CAGR of 28.6% and PAT CAGR of 34.3%. Users generally treated these figures as part of the pre-listing narrative. The listing pop changed the arithmetic because the price moved, not the FY26 base numbers. That shift is why valuation became the centre of post-IPO discussion.

After listing: the discount argument gets tested

At ₹1,200, investors immediately recalculated multiples using the post-listing P/E cited at 61.85x. That figure is higher than the 44.9x multiple used in most pre-IPO research notes. It is also above the peer average figures that were referenced in those same notes. As a result, the “priced at a discount” framing became harder to sustain at the listing price. Some posts described this as the market pulling forward future growth expectations. Others called it a reminder that IPO pricing and secondary-market pricing solve for different demand levels. The market cap at listing of ₹24,546 crore was also compared with a post-issue market cap estimate of about ₹17,816 crore at the IPO price. This gap mattered because it framed how quickly valuation expanded within a single session. The practical implication shared by commenters was simple: higher multiples leave less room for disappointment on margins or earnings.

Subscription versus debut pop: why both showed up

One thread noted the IPO was subscribed 0.62 times on Day 1. The retail portion was cited at 0.76 times on the same day. Despite that early subscription snapshot, the stock still debuted around a 38% premium. Social media users debated whether early subscription data can mislead when it is only Day 1. Others argued that sentiment can shift sharply into the final days and into listing, as suggested by the rising GMP updates. The GMP narrative itself was used as a bridge between subscription chatter and listing outcomes. Another angle was that listing price reflects secondary-market willingness to pay at that moment. In that framing, IPO subscription and listing demand are related but not identical indicators. The result is that both “muted early subscription” and “strong debut” can coexist in the same deal timeline.

What investors are watching from here

Post-IPO discussion has largely converged on two checkpoints: earnings delivery and margin stability. With PAT margin cited at 8.70% in FY26, users are watching whether profitability can catch up with revenue growth. Return ratios are another focus because ROE and ROCE were shown lower year-on-year in the shared tables. The adjusted ROE and ROCE numbers excluding unused cash are also being tracked as a more comparable lens. Valuation is the third pillar because the P/E expansion to 61.85x was a central post-listing datapoint. Some posts noted that a sharp premium can be positive but still raise the hurdle for future quarters. The debate is less about whether the debut was strong, and more about what must happen next to justify the rerating. For many investors, the near-term question is whether business momentum sustains while the market prices in higher growth. For others, the question is whether the stock can consolidate after a first-day revaluation.